Literature DB >> 18853965

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.

Deepak L Bhatt1, James Scheiman, Neena S Abraham, Elliott M Antman, Francis K L Chan, Curt D Furberg, David A Johnson, Kenneth W Mahaffey, Eamonn M Quigley, Robert A Harrington, Eric R Bates, Charles R Bridges, Mark J Eisenberg, Victor A Ferrari, Mark A Hlatky, Sanjay Kaul, Jonathan R Lindner, David J Moliterno, Debabrata Mukherjee, Richard S Schofield, Robert S Rosenson, James H Stein, Howard H Weitz, Deborah J Wesley.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18853965     DOI： 10.1111/j.1572-0241.2008.02216.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  30 in total

1.  Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes.

Authors:  Takahisa Furuta; Takayuki Iwaki; Kazuo Umemura
Journal:  Br J Clin Pharmacol       Date:  2010-09       Impact factor: 4.335

2.  Identification of a high-risk group for low-dose aspirin-induced gastropathy by measuring serum pepsinogen in H. pylori-infected subjects.

Authors:  K Iijima; T Koike; N Ara; K Nakagawa; Y Kondo; K Uno; W Hatta; N Asano; A Imatani; T Shimosegawa
Journal:  J Gastroenterol       Date:  2014-06-22       Impact factor: 7.527

3.  Management for non-variceal upper gastrointestinal bleeding in elderly patients: the experience of a tertiary university hospital.

Authors:  Koichiro Kawaguchi; Hiroki Kurumi; Yohei Takeda; Kazuo Yashima; Hajime Isomoto
Journal:  Ann Transl Med       Date:  2017-04

4.  Frequency of nonsteroidal anti-inflammatory drug-associated ulcers.

Authors:  Hideyuki Hiraishi; Ryo Oki; Kohei Tsuchida; Naoto Yoshitake; Keiichi Tominaga; Koji Kusano; Takashi Hashimoto; Mitsunori Maeda; Takako Sasai; Tadahito Shimada
Journal:  Clin J Gastroenterol       Date:  2012-04-24

5.  ACG Clinical Guideline: Management of Patients With Acute Lower Gastrointestinal Bleeding.

Authors:  Lisa L Strate; Ian M Gralnek
Journal:  Am J Gastroenterol       Date:  2016-03-01       Impact factor: 10.864

Review 6.  Identification of NSAID users at risk for gastrointestinal complications: a systematic review of current guidelines and consensus agreements.

Authors:  Merel M Tielemans; Ties Eikendal; Jan B M J Jansen; Martijn G H van Oijen
Journal:  Drug Saf       Date:  2010-06-01       Impact factor: 5.606

Review 7.  Variability in response to clopidogrel: how important are pharmacogenetics and drug interactions?

Authors:  Terry K W Ma; Yat-Yin Lam; Victoria P Tan; Bryan P Yan
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

Review 8.  Individualized therapy for gastroesophageal reflux disease: potential impact of pharmacogenetic testing based on CYP2C19.

Authors:  Takahisa Furuta; Mitsushige Sugimoto; Naohito Shirai
Journal:  Mol Diagn Ther       Date:  2012-08-01       Impact factor: 4.074

9.  Critical appraisal of a fixed combination of esomeprazole and low dose aspirin in risk reduction.

Authors:  Ravi Vachhani; Doumit Bouhaidar; Alvin Zfass; Bimaljit Sandhu; Ali Nawras
Journal:  Ther Clin Risk Manag       Date:  2010-06-24       Impact factor: 2.423

Review 10.  Leveraging the electronic health record to improve quality and safety in rheumatology.

Authors:  Gabriela Schmajuk; Jinoos Yazdany
Journal:  Rheumatol Int       Date:  2017-08-29       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.